http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AtriCure (ATRC) Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 202
-
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
-
CPI Aerostructures (CVU) Awarded Lot 4 Production Contract of Next Generation Jammer Mid-Band Program by Raytheon Technologies
-
NV5 Global (NVEE) Enters Agreement to Acquire Group Delta
-
Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
-
Alliance of Channel Women Names 2025-26 Board of Directors
-
CFO Tech Announces Official Launch for 2025, Transforming Business Financial Management with Advanced Solutions
-
Healthcare M&A Volume Drops in Q4:24, According to Acquisition Data from LevinPro HC
-
Next-Gen Toshiba Printers Elevate Industrial Barcode Labeling
-
Save A Lot Donates Over 67,000 Bags of Food to Charities Across the Country
-
American Resources Corporation's ReElement Technologies and LVC Global Holdings Launch "ReElement Middle East" to Advance Critical Minerals Processing in the Region
-
Trinity Capital Inc. Funds a Record $1.2 Billion of Investments in 2024
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
-
ENGIE and Meta announce new 200 MW renewable energy agreement expanding existing relationship to meet growing power demand
-
CPI Aerostructures Awarded Lot 4 Production Contract of Next Generation Jammer Mid-Band Program by Raytheon Technologies
-
NV5 Enters Agreement to Acquire Group Delta; Strengthens Southern California Infrastructure Engineering, Testing, and Environmental Services
-
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
-
STL Announces Self-Certification of its Build America Buy America (BABA/BEAD)-compliant Optical Products
-
Michelle Sidwell Rejoins Velo3D as Chief Revenue Officer
-
Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum
-
Slate Asset Management Promotes Steven Dejonckheere to Managing Director
-
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
-
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
-
nbkc bank Selects NCR Atleos Allpoint to Expand Access to Self-Service Banking
-
DTE Energy spends $3.3 billion with Michigan suppliers in 2024
-
Context Therapeutics (CNTX) Appoints Andy Pasternak as Board Chair
-
22nd Century Group (XXII) Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
-
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
-
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
-
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
-
Novocure (NVCR) Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
-
Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conf
-
Moderna (MRNA) updates 2025 expected revenue range to $1.5 to 2.5 billion
-
Bristol-Myers Squibb (BMY) and ArsenalBio Achieve Milestone for AB-4000 Series
-
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
-
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
-
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
-
Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases
-
Tantalus Systems Announces Appointment of Azim Lalani as Chief Financial Officer
-
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
-
BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million
-
ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors
-
Porter Secures Sale and Leaseback with Avolon for Four Pratt & Whitney PW1921G Engines
-
Nevada Lithium to Participate in the “2025 Mining Conference: Mining and Supplying Critical Minerals & Precious Metals”
-
Kobo Resources Reports High-Grade Gold Intercepts: 11.0 m at 6.77 g/t Au and 4.0 m at 6.38 g/t Au; Early Exploration Success at Contact Zone with 6.0 m at 1.94 g/t Au
-
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
-
SpringWorks Therapeutics Inc. (SWTX) Reports Prelim Q4 Results, Provides Business Updates
-
Comstock Mining (LODE) Releases Shareholder Letter
